BIVI BioVie Inc.

0.9098USD-3.50%Mkt Cap: 9.76M USDP/E: —

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that i…

Insiders, last 90 days5 buys
Institutional holders16 on file

Key Statistics

Company
Market Cap9.76M USD
Enterprise Value2.63M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-22.07M USD
Revenue/Share—
Last Price0.9098 USD
Fiscal Year EndJun 2026
MR QuarterSep 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.60
PEG—
EV/EBITDA-0.12
EV/Revenue—
P/S—
P/B1.21
EPS (TTM)-2.85 USD
EPS (Forward)-0.57 USD
52W Range
0.82003% of range3.790
52W High3.790 USD
52W Low0.8200 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-214.92%
ROA-154.89%
ROIC-1141.01%
ROCE-216.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.02M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-109.80%
Net Debt-7.48M USD
Net Debt/EBITDA0.33
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio2.40
Quick Ratio1.83
Book Value/Sh0.75 USD
Cash/Share0.72 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateNov 22, 2019
Splits
Last Split1:10
Split DateJul 7, 2025
Analyst Consensus
Rating—
Target (Mean)5.255 USD
Upside (mean)+477.6%
Target Range5.000 USD – 5.510 USD
5.000+477.6% to mean5.510
# Analysts2
Ownership
Shares Out.10.72M
Float10.66M
Insiders0.39%
Institutions16.47%
Short Interest
Short Ratio3.3d
Short % Float7.60%
Short % Out.6.78%
Shares Short589.06K
Short (prev mo.)831.30K
Technical
SMA 501.460 (-37.7%)
SMA 2001.522 (-40.2%)
Beta0.80
S&P 52W Chg12.08%
Avg Vol (30d)653.19K
Avg Vol (10d)1.64M
Technical Indicators
RSI (14)33.9
MACD-0.1148
MACD Signal-0.0760
MACD Hist.-0.0388
BB Upper1.655 USD
BB Middle1.267 USD
BB Lower0.8786 USD
BB Width61.29%
ATR (14)0.1660 USD
Vol Ratio (20d)0.18x

About BioVie (NASDAQ: BIVI)

›

BioVie (NASDAQ: BIVI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 13 employees.

The shares were at 0.9098 USD on 19 November 2026, down 39.3% over 52 weeks. Its 52-week range is 0.8200 USD to 3.790 USD: the price is 76.0% below the high and 11.0% above the low.

Its market capitalisation is 9.76M USD.

BioVie reports return on equity of -214.9% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 7.48M USD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. The next earnings report is expected on 5 February 2027.